Health Capital Helsinki (HCH) invites innovative pharmaceutical companies to join as Founding Pharma Partners. This entry-level partnership offers a way to demonstrate commitment to advancing health innovations in the Helsinki Metropolitan area – Finland’s leading health and life science hub.
HCH Alliance
HCH is a strategic alliance of the Cities of Helsinki and Espoo, Helsinki University Hospital (HUS), University of Helsinki, Aalto University, Metropolia University of Applied Sciences, and Haaga-Helia University of Applied Sciences.
Why join as a Founding Pharma Partner?
Becoming a Founding Pharma Partner means supporting the development of a dynamic, innovation-driven health ecosystem. This light-touch, non-commercial partnership demonstrates your organization’s commitment to advancing public-private partnerships to drive health innovation.
Regional Collaboration as a Catalyst for Impact
Health innovations often emerge and mature within strong regional ecosystems. As a Founding Pharma Partner, you will be part of a locally anchored, globally connected network that offers:
- Agility and speed – Regional initiatives can respond faster than national-level programs, making them ideal for piloting, iterating, and scaling successful solutions.
- Global insights with local execution – HCH provide a platform to adapt proven international models to the Finnish context.
- Strategic influence – Many transformative innovations originate within regional ecosystems; HCH is Finland’s largest health innovation hub and a model for national and international replication.
Key benefits of partnership
As a Founding Pharma Partner, your organization will receive:
- Recognition as a Founding Pharma Partner in HCH communication and selected materials
- Networking opportunities with academic, clinical, and industry leaders through HCH events and activities
- Information on potential collaboration opportunities and joint initiatives within the ecosystem
Note that project design, building or management services are available separately as fee-based offerings.
Annual contribution
The annual membership fee for Founding Pharma Partner status is €3,000, supporting HCH’s non-commercial mission to strengthen the regional health and life sciences ecosystem.
The Founding Pharma Partners program will be officially launched during the Radical Health Festival at an evening reception hosted by the Mayor at Helsinki City Hall on January 20th.
Contact:
Health Capital Helsinki Lead
heli.salminen@helsinki.fi
Health Capital Helsinki Ecosystem Manager
rauni.korolainen@helsinki.fi
